Capitolis Advisors LLC Boston Scientific Corp Transaction History

Capitolis Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$35.24 - $47.1 $353,210 - $472,083	-10,023 Reduced 64.99%	5,399 $201,000
Q1 2022 May 12, 2022	SELL	$40.9 - $45.1 $1.4 Million - $1.54 Million	-34,172 Reduced 68.9%	15,422 $683,000
Q3 2021 Nov 12, 2021	SELL	$41.23 - $45.88 $561,676 - $625,023	-13,623 Reduced 21.55%	49,594 $2.12 Million
Q2 2021 Aug 11, 2021	SELL	$38.58 - $44.24 $776,808 - $890,772	-20,135 Reduced 24.16%	63,217 $2.7 Million
Q4 2020 May 07, 2021	BUY	$33.15 - $41.97 $2.76 Million - $3.5 Million	83,352 New	83,352 $3 Million

1,543

1.19B

6.79M

10.1M

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $129B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

Get notified when there are updates to the investment portfolio of Capitolis Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Capitolis Advisors LLC with notifications on news.